Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Perez

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2021
Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic CancerHarshabad Singh, Kimberly Perez, Brian M Wolpin, et al.
Family Medicine|February 5, 2003
Cervical cancer rates and the supply of primary care physicians in FloridaRobert J Campbell, Arnold M Ramirez, Kimberly Perez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic AdenocarcinomaKimberly Perez, Thomas E Clancy, Joseph D Mancias, et al.
Annals of Nuclear Medicine|June 19, 2021
Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasmsShawn Karls, Richard Gold, Sasha Kravets, et al.
BMC Cancer|August 2, 2015
Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cellsHillary E Mulvey, Audrey Chang, Jason Adler, et al.
The Oncologist|February 20, 2010
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Leukemia & Lymphoma|October 6, 2010
Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
HIV-negative plasmablastic lymphoma: not in the mouthJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
BMC Cancer|October 9, 2013
RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patientsSam Cross-Knorr, Shaolei Lu, Kimberly Perez, et al.
American Journal of Clinical Oncology|February 8, 2011
Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trialThomas Dipetrillo, Mohan Suntharalingam, Thomas Ng, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2021
Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic CancerHarshabad Singh, Kimberly Perez, Brian M Wolpin, et al.
Family Medicine|February 5, 2003
Cervical cancer rates and the supply of primary care physicians in FloridaRobert J Campbell, Arnold M Ramirez, Kimberly Perez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic AdenocarcinomaKimberly Perez, Thomas E Clancy, Joseph D Mancias, et al.
Annals of Nuclear Medicine|June 19, 2021
Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasmsShawn Karls, Richard Gold, Sasha Kravets, et al.
BMC Cancer|August 2, 2015
Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cellsHillary E Mulvey, Audrey Chang, Jason Adler, et al.
The Oncologist|February 20, 2010
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Leukemia & Lymphoma|October 6, 2010
Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
HIV-negative plasmablastic lymphoma: not in the mouthJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
BMC Cancer|October 9, 2013
RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patientsSam Cross-Knorr, Shaolei Lu, Kimberly Perez, et al.
American Journal of Clinical Oncology|February 8, 2011
Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trialThomas Dipetrillo, Mohan Suntharalingam, Thomas Ng, et al.
Pageof 7